Clinical Trials >> HIV-1 – NEWLY DIAGNOSED or TREATMENT NAIVE

HIV-1 – NEWLY DIAGNOSED or TREATMENT NAIVE

HIV (human immunodeficiency virus) is a virus that attacks the body’s immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome).  There is currently no effective cure. Once people get HIV, they have it for life.  But with proper medical care, HIV can be controlled. People with HIV who get effective HIV treatment can live long, healthy lives and protect their partners.

This research study is testing an investigational drug in people who have never taken any antiretroviral therapies (ART) to treat their HIV.  Researchers will assess how well it slows the growth of the HIV virus, and how it works in the body compared to an approved 3-drug medicine.

The study will last approximately 2 yrs with 13 clinic visits. 

 

A few qualifications to participate are: 

  • HIV-1 positive adults
  • Have not taken any ART medications since being diagnosed with HIV

Qualified participants will:

  • See a physician at no cost
  • Receive medication and labs at no cost
  • Receive compensation for time and travel  

Currently Enrolling Studies


We are currently seeking participants for different clinical research studies. Click below to learn about our current trials and summit your information. We will reach out to you very quickly to answer any questions you may have and see if you qualify.